REMEGEN

RemeGen, Ltd. ("RemeGen") is a biopharmaceutical company in China dedicated to fulfilling unmet medical needs for patients with life-threatening conditions. RemeGen's main focus is research and development, manufacturing and commercialization of novel biologics, most notably monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs). Headquartered in Yantai, Shandong Province, China, RemeGen has labs/offices in Beijing and California.

#SimilarOrganizations #People #Financial #More

REMEGEN

Industry:

Biotechnology Health Care Therapeutics

Founded:

2008-01-01

Status:

Active

Contact:

(86) 535-6113513

Email Addresses:

[email protected]

Total Funding:

100 M USD

Technology used in webpage:

SPF Apache PHP Apache 2.2 Alibaba Alibaba Cloud MailBox Win32 Header Apache Tomcat JK AliDNS

Similar Organizations

mabspace-biosciences-logo

MabSpace Biosciences

MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.

Current Advisors List

wang-weidong_image

Wang Weidong Board Chairman @ Remegen
Board_member

Current Employees Featured

jianmin-fang_image

Jianmin Fang
Jianmin Fang Co-Founder, CEO and CSO @ Remegen
Co-Founder, CEO and CSO

Founder

jianmin-fang_image

Jianmin Fang

wang-weidong_image

Wang Weidong

Stock Details

Company's stock symbol is SSE:688331

Investors List

lilly-asia-ventures_image

Investments List

Date	Company	Article	Money raised
2022-08-19	Biocytogen	Remegen investment in Post-IPO Equity - Biocytogen	49.8 M USD